Strategic Ancillary Cannabis Investing
The Arcadian Fund is a professionally managed vehicle capitalizing upon the non-touch, ancillary cannabis industry growth. More specifically, Arcadian focuses on mid to late stage companies that are primarily looking for resources in order to sustain and increase growth backed by a proven track record.
Cannabis-related companies raised more than $734 million between January 1st and April 21st, 2017. Resulting in a 7X increase from the $108 million raised in the same period last year according to Arcview.
There are many advantages that the ancillary sector has, such as it avoids regulatory hurdles, it enables Inter-State Commerce, and it allows brand expansion.
The ancillary cannabis market grew 161.2% in 2016. Consulting increased 737%, investment / M&A up 366%, and consumption devices increased 116%.
The introduction of Adult Use in CO and WA have resulted in a 70% year over year compounded growth rate.
Market and industry insiders are forecasting the national legal demand for cannabis to increase to $22 Billion by 2020.
Arcadian and partners predict a 3-5 times multiple expansion into ancillary revenue. This would result in the California ancillary market alone increasing to a minimum of $36 billion by 2018.
9663 Santa Monica Blvd, #1038, Beverly Hills, California 90210, United States
Monday - Friday: 9am - 5pm